Recombinant‐follicle stimulating hormone is more effective than urinary human menopausal gonadotropin in ovarian hyperstimulation for assisted reproductive technology treatment

Lignende værker

• Reduction of perifollicular arterial blood flow resistance after hCG administration is a good indicator of the recovery of mature oocytes in ART treatment
  af: Nakagawa, Koji, et al.
  Udgivet: (2006)
• Intraovarian arterial blood flow resistance in oligomenorrheal infertile women
  af: Nakagawa, Koji, et al.
  Udgivet: (2006)
• The frequency of ovulation from the affected ovary decreases following laparoscopic cystectomy in infertile women with unilateral endometrioma during a natural cycle
  af: Horikawa, Takashi, et al.
  Udgivet: (2008)
• Elevated basal FSH levels, if it is under 15 IU/L, will not reflect poor ART outcomes
  af: Kojima, Rieko, et al.
  Udgivet: (2008)
• The ratio of late-follicular to mid-follicular phase LH concentrations efficiently predicts ART outcomes in women undergoing ART treatment with GnRH-agonist long protocol and stimulation with recombinant FSH
  af: Nakagawa, Koji, et al.
  Udgivet: (2008)